Bioisosterism

Bioisosterism is a rational design strategy in medicinal chemistry that systematically replaces molecular fragments with structurally different but physicochemically similar chemical groups to optimize pharmacological properties while preserving the desired biological activity of a lead compound.

12.4K

Publications

570.4K

Citations

33K

Authors

3.1K

Institutions

Publications per year

2017–2026

703

Authors

33K

  1. EJ
    E. J. Corey

    Harvard University, United States

    49 publications · 4.7K citations

    37

    h-index

  2. CD
    Carl Djerassi

    Stanford University, United States

    62 publications · 2.1K citations

    27

    h-index

  3. BM
    Barry M. Trost

    Stanford University, United States

    25 publications · 1.8K citations

    23

    h-index

  4. KF
    Karl Folkers

    The University of Texas at Austin, United States

    42 publications · 2.1K citations

    23

    h-index

  5. HR
    Henry Rapoport

    University of California, Berkeley, United States

    32 publications · 1.4K citations

    21

    h-index

1–5 of 33K

Venues

  1. Journal of the American Chemical Society

    JACS · 3.3K publications · 176.1K citations

    159

    h-index

  2. Biochemistry

    654 publications · 42.7K citations

    102

    h-index

  3. The Journal of Organic Chemistry

    JOC · 2.4K publications · 85.9K citations

    96

    h-index

  4. Journal of Medicinal Chemistry

    526 publications · 29.3K citations

    77

    h-index

  5. Angewandte Chemie International Edition

    119 publications · 12.3K citations

    61

    h-index

1–5

See also

Bioisosterism

Core Methods

Applications

Variants

Evaluation